Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Ibrutinib-venetoclax bij CLL leidt vaker tot niet-detecteerbare MRD
sep 2025 | Leukemie